Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-002146
Filing Date
2023-01-05
Accepted
2023-01-05 20:01:41
Documents
1
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4041
  Complete submission text file 0001209191-23-002146.txt   5636
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710
Business Address
Dubensky Thomas W. (Reporting) CIK: 0001635590 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 23513262